Share Crazy

Member Login Trade Shares Stock Quotes Site Search
Register Community Message Board Buy Books Rumour Mill Stock Quotes Stockwatch Subscriptions SuperMarket Level
Bulletin Board references for Alliance Pharma Search BB
Current Price Information for Alliance Pharma (APH) Add to Stockwatch
DateCurrentChangeTo Buy To Sell Intra High Intra Low Intra Vol
30-07-201033.25+0.25 (0.76%)33.2533.0033.2533.00160,323
Share rise
Alliance Pharma has risen today. To learn about spread betting on rising stocks and to receive a free subscription for topspreadbets.com when you join, click here: www.t1pspreadbetting.com
Historic Price Info (all prices in GB pence)
12 Mth HighDate12 Mth Low Date1 Wk Ago 1 Mth Ago 1 Year Ago
36.2507-04-201015.5003-08-200933.25 (+0%)32.50 (+2.31%)15.50 (+114.52%)
* Prices are 15 minutes delayed
Activities
Alliance Pharma is an emerging speciality pharmaceutical company. The company has a strong track record of acquiring the rights to established niche brands and owns, or shares, the rights to 30 branded pharmaceutical products and continues to explore opportunities to expand the range. Alliance Pharma's products are prescribed in the treatment of a wide range of conditions and include brands used in periodontitis (a serious gum disease), the prevention of heart disease, in Parkinson's disease, in nutrition, in nasal infections, in the treatment of dermatological conditions and in childbirth. Alliance Pharma's sales are mainly prescription driven. Its products are distributed to hospitals directly and to pharmaceutical wholesalers which service both hospital and retail pharmacies with their prescription requirements. Alliance Pharma is also developing novel products for sleep disorders and the induction of labour.
Contact Details
Avonbridge House, Bath Road, Chipperham, Wiltshire SN15 2BB.
Telephone+44 (0)1249 466 966Websitehttp://www.alliancepharma.co.uk/
RegistrarsCapita RegistrarsReg Tel 0870 162 3100
StockbrokersNumis Securities  
Fundamental Info   
Shares in Issue232,533,373 (Ord 1p) SEAQ/EpicAPH
SEDOL3103081
Annualised Dividend0.0700 Dividend Cover33.86
Latest Pay date15-07-2010 Latest Ex-Div date16-06-2010
EPS2.37 FloatedNov 01
Market Capitalisation (£m) 77.317 Enterprise Value (£m) 116.383
SectorPharmaceuticals & Biotechnology % of Sector by Cap 0.066
IndustryPharmaceuticals % of Industry by Cap 0.067
Last RNS Announcement 30-07-2010 ListingAIM
Last Annual Results 24-03-2010 Last Interim Results 09-09-2009
Total Assets (m)56.800Total Liabilities (m)40.170
Total Equity (m)16.630Cash & Equivalents (m)1.104
Net Gearing (%) 68.778 Gross Gearing (%) 70.722
Net Assets (m) 16.630 Op Cash Flow (m) 10.389
Debt Ratio63.332 Debt-to-Equity0.715
Assets/Equity3.416 Cash/Equity6.639
Quick Ratio0.765 Current Ratio1.025
Traded Volume: More...Number of trades9Trading Closed 
Bought Volume49,323Sold Volume11,000Unknown Volume150,000
First Auction Price0Last Auction Price-Last Auction Time-
Last Auction Vol-Quote Size1Market Size9,000
Minimum Order0Maximum Order899,999,929Maximum Order Days0
Last Trade TickDOWNVWAP (all trades)33.0825VWAP (auto trades)0
Uncrossed Price0Uncrossed Time0Uncrossed Volume0
Name change history
DateShareWhat Happened?
24-12-2003 Peerless Technology Renamed to Alliance Pharma
Share Adjustments
DateIssueFactorDetails
01-12-2003 Open Offer 0.93333 1-for-2 open offer at 16.00p per share.
One Year Chart Click for Full Charting facilities
Broker and Press Comments - Expand/Show All
DateCommentMore
01-04-2010 -0.25, (32.75) IC says Buy (35p): BULL POINTS Strong product sales - New investors on board - ...
16-03-2010 -0.25, (34.75) an article in the Times reports: Alliance Pharma rose 0.75p to 35p after it em ...
18-03-2009 +1, (8.25) announces a six-fold increase rise in 2008 pretax profit on demand for its dermato ...
19-01-2009 an article in the Times reports: Alliance Pharma fell 0.25p to 4.375p as speculation circula ...
08-01-2009 +0.5, (4.38) the specialty pharmaceutical company says it expects 2008 results to significant ...
12-09-2007 +0, (7.75) Numis has raised its rating for Alliance Pharma PLC to 'Add' from 'Hold' on the ex ...
11-11-2004 +0, (16) an article in the Times reports: the shares were unchanged at 16p, despite the decla ...
03-02-2004 +0, (24.5) an article in the Times reports: the shares rose 1.5p to 24.5p as Numis Securities ...
24-12-2002 +0, (17) an article in the Times reports: the shares were unchanged at 17p, the cash shell fl ...
Latest RNS Information - Show More
DateTimeHeadlineMore
30-07-2010 16:10:00 Alliance Pharma PLC Major Interests in SharesDetails
30-07-2010 11:32:00 Alliance Pharma PLC Major Interest in SharesDetails
29-07-2010 15:02:00 Alliance Pharma PLC Major Interests in SharesDetails
22-07-2010 16:44:00 Alliance Pharma PLC Exercise of OptionsDetails
15-07-2010 16:59:00 Alliance Pharma PLC Major Interests in SharesDetails
09-07-2010 15:20:00 Alliance Pharma PLC Major Interest in SharesDetails
07-07-2010 09:07:00 Alliance Pharma PLC Exercise of OptionsDetails
06-07-2010 11:53:00 Alliance Pharma PLC Exercise of OptionsDetails
06-07-2010 07:00:00 Alliance Pharma PLC Pre-Close Trading UpdateDetails
05-07-2010 12:18:00 Alliance Pharma PLC Major Interest in SharesDetails
01-07-2010 16:26:00 Alliance Pharma PLC CULS ConversionDetails
22-06-2010 10:15:00 Alliance Pharma PLC Major Interest in SharesDetails
22-06-2010 07:00:00 Alliance Pharma PLC Director ShareholdingDetails
07-06-2010 11:49:00 Alliance Pharma PLC CULS ConversionDetails
27-05-2010 07:00:00 Alliance Pharma PLC AGM StatementDetails
20-05-2010 10:05:00 Alliance Pharma PLC CULS ConversionDetails
10-05-2010 15:35:00 Alliance Pharma PLC CULS Conversion and Additional ListingDetails
07-05-2010 07:00:00 Alliance Pharma PLC Major Interest in SharesDetails
04-05-2010 12:04:00 Alliance Pharma PLC Exercise of OptionsDetails
29-04-2010 14:55:00 Alliance Pharma PLC Share OptionsDetails
Recent Director Dealings
DateDirectorTransAmountTypePrice (p)Value (£)Holding%
07-07-2010 A.R. Booley SELL 25,584 ORD 32.75 8,379 6,810,723 2.9
06-07-2010 A.R. Booley SELL 79,416 ORD 32.75 26,009 6,810,723 2.9
06-07-2010 A.R. Booley EX 76,416 OPT 9.25 7,068 - -
06-07-2010 A.R. Booley EX 25,584 OPT 9.25 2,367 - -
26-03-2010 A.R. Booley SELL 489,250 ORD 33.25 162,676 6,810,723 3
26-03-2010 A.R. Booley EX 489,250 OPT 16.5 80,726 - -
05-02-2010 T.T. Casdagli TAKE 1,900,000 ORD 26 494,000 19,300,000 8.69
09-01-2009 A. Booley BUY 100,000 ORD 4 4,000 6,810,723 4.2
27-10-2008 M. Gatenby BUY 220,000 ORD 4 8,800 350,000 0.22
15-10-2008 R. Wright BUY 100,000 ORD 4 4,000 190,768 0.12
Basic Result Information (figures in Millions unless specified)
DateTypeTurnoverProfitEPS (p)Dividend (p)Currency
31-12-2009 Full Year 31.24 5.74 2.37 0.30 GBX
30-06-2009 Interim 13.23 2.89 1.28 0.07 GBX
31-12-2008 Full Year 21.76 2.42 1.55 - GBX
30-06-2008 Interim 9.90 1.02 0.90 - GBX
31-12-2007 Full Year 18.22 -3.21 -1.98 - GBX
30-06-2007 Interim 7.75 -0.91 -0.56 - GBX
31-12-2006 Full Year 17.25 0.49 0.32 - GBX
30-06-2006 Interim 7.80 -0.18 -0.11 - GBX
31-12-2005 Full Year 12.28 0.66 0.45 - GBX
31-08-2005 Interim 7.55 0.37 0.26 - GBX
28-02-2005 Full Year 11.83 0.42 0.34 - GBX
31-08-2004 Interim 5.57 -0.39 -0.35 - GBX
29-02-2004 Full Year 10.42 -2.15 -2.44 - GBX
30-06-2003 Interim 0.00 -0.07 -0.07 - GBX
31-12-2002 Full Year 0.00 -0.07 -0.47 - GBX
30-06-2002 Interim 0.00 -0.02 -0.01 - GBX
31-12-2001 Full Year 0.00 -0.04 -1.01 - GBX
Balance Sheet & Cash Flow Click Here to view
Dividend History (NOT adjusted for any capital changes)
PeriodEx-DatePay DateNet DividendCurrencyTotal for year
H2 Dividend 16-06-2010 15-07-2010 0.2300 GBX 0.3000
H1 Dividend 02-12-2009 15-01-2010 0.0700 GBX
Recent Major Shareholder Transactions
Restricted page

In order to view this section, you need to be logged in. Log in

If you do not have an account, you can register for one (it's Free!!). Register

Recent changes to Share Capital
Date+/-SharesTotal SharesReason
07-07-2010 + 951,427 232,414,623 CULS Conversion.
11-06-2010 + 976,189 231,463,196 CULS Conversion.
26-05-2010 + 1,525,950 230,487,007 Convertible Unsecured Loan Stock.
14-05-2010 + 952,380 228,961,057 Conversion notice in respect of GBP200,000 nominal value of the Company’s 8% Convertible Unsecured Loan Stock.
10-05-2010 + 49,150 228,008,677 Exercise of share options.
07-04-2010 + 1,785,713 227,959,527 CULS Conversion.
06-04-2010 + 489,250 226,173,814 Exercise of executive share options.
25-03-2010 + 3,519,012 225,684,564 Exercise of executive share options.
22-02-2010 + 28,846,154 222,165,552 Placing for cash at 26p per share.
11-12-2009 + 57,625 193,319,398 Exercise of share options.
Director History
DateInitSurnamePositionLeave
23-12-2003 A.R. Booley Sales Director -
22-02-2010 P.J. Butterfield Executive Director -
03-03-2009 T.T. Casdagli Non-Executive Director -
23-12-2003 J. Dawson Chief Executive Officer -
01-02-2004 M.R.B. Gatenby Non-Executive Chairman -
23-12-2003 P. Ranson Non-Executive Director -
08-06-2006 A.L. Smith Non-Executive Director -
27-06-2007 R. Wright Finance Director -
08-11-2001 A. Ahmed Non-Executive Chairman 23-12-2003
23-12-2003 S.A. Dawson Executive Director 16-05-2007
08-11-2001 J.M. Fenn Managing Director 23-12-2003
08-11-2001 S.C.A. Harris Non-Executive Director 16-02-2004
08-11-2001 R.M. James Executive Director 23-12-2003
23-12-2003 M.E. Scott Finance Director 16-05-2007
10-01-2007 M.J. Tomlinson Medical Director 17-07-2009
Share Information provided by ShareData Services Please report any errors or contact us for feedback.

© 2000-2008 ShareCrazy.com Ltd



Other recommended websites

UK Analyst
t1ps.com
Trader Tom
Wats Hot
UnQuoted Analyst
UK 350
t1ps SpreadBetting
Small Caps Shares
Zak's TA
Free City Seminars
Chart Guide
Top Spreadbets
John Piper's Trading
All New Issues
UK Microcap
The Aim & Plus Newsletter
Oil Barrel
Elizabeth Robert
GFT CFDs FX Spreadbets
Saxo Bank
Saxo Bank